$DGX
Quest Diagnostics Inc

2012 Q1 Form 10-Q Financial Statement

#000102207912000005 Filed on April 27, 2012

View on sec.gov

Income Statement

Concept 2012 Q1 2011 Q4 2011 Q1
Revenue $1.909B $1.848B $1.794B
YoY Change 6.41% 1.33% -0.64%
Cost Of Revenue $1.109B $1.077B $1.097B
YoY Change 1.11% -0.28% 2.87%
Gross Profit $800.0M $779.4M $704.6M
YoY Change 13.55% 4.82% -4.68%
Gross Profit Margin 41.91% 42.17% 39.27%
Selling, General & Admin $483.3M $443.1M $447.9M
YoY Change 7.9% 4.68% 7.17%
% of Gross Profit 60.41% 56.85% 63.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $72.17M $71.70M $63.37M
YoY Change 13.9% 12.74% 0.1%
% of Gross Profit 9.02% 9.2% 8.99%
Operating Expenses $483.3M $462.7M $447.9M
YoY Change 7.9% 7.08% 4.71%
Operating Profit $297.8M $316.7M $30.96M
YoY Change 861.95% 1.67% -90.06%
Interest Expense $42.99M -$36.60M $38.28M
YoY Change 12.3% 19.61% -236.71%
% of Operating Profit 14.43% -11.56% 123.64%
Other Income/Expense, Net -$29.74M $3.600M -$28.02M
YoY Change 6.12% 9.09% -567.03%
Pretax Income $269.6M $292.2M $2.938M
YoY Change 9076.92% 9.48% -98.94%
Income Tax $102.6M $92.90M $49.23M
% Of Pretax Income 38.04% 31.79% 1675.49%
Net Earnings $159.0M $189.4M -$53.86M
YoY Change -395.2% 14.29% -133.16%
Net Earnings / Revenue 8.33% 10.25% -3.0%
Basic Earnings Per Share $1.00 $1.20 -$0.33
Diluted Earnings Per Share $0.99 $1.19 -$0.33
COMMON SHARES
Basic Shares Outstanding 158.3M shares 161.5M shares
Diluted Shares Outstanding 159.7M shares 161.5M shares

Balance Sheet

Concept 2012 Q1 2011 Q4 2011 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $145.0M $165.0M $994.0M
YoY Change -85.41% -63.25% 114.69%
Cash & Equivalents $145.4M $165.0M $994.2M
Short-Term Investments
Other Short-Term Assets $399.3M $329.9M $293.0M
YoY Change 36.27% 40.99% 23.63%
Inventory $88.26M $89.13M $72.00M
Prepaid Expenses
Receivables $973.9M $906.5M $940.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.519B $1.401B $2.300B
YoY Change -33.97% -12.69% 39.82%
LONG-TERM ASSETS
Property, Plant & Equipment $781.4M $799.8M $822.0M
YoY Change -4.94% -4.1% 1.23%
Goodwill $5.835B $5.796B
YoY Change 13.6%
Intangibles $1.042B $1.036B
YoY Change
Long-Term Investments $45.02M
YoY Change
Other Assets $274.8M $281.0M $189.0M
YoY Change 45.41% 48.66% 18.87%
Total Long-Term Assets $7.933B $7.912B $6.925B
YoY Change 14.55% 14.29% 0.79%
TOTAL ASSETS
Total Short-Term Assets $1.519B $1.401B $2.300B
Total Long-Term Assets $7.933B $7.912B $6.925B
Total Assets $9.451B $9.313B $9.225B
YoY Change 2.45% 9.21% 8.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $971.0M $907.0M $1.137B
YoY Change -14.6% 4.86% 25.5%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $554.0M $569.4M $629.0M
YoY Change -11.92% 63.15% 270.0%
Total Short-Term Liabilities $1.525B $1.561B $1.767B
YoY Change -13.67% 28.6% 64.22%
LONG-TERM LIABILITIES
Long-Term Debt $3.365B $3.371B $3.595B
YoY Change -6.4% 27.64% 22.07%
Other Long-Term Liabilities $664.7M $666.7M $626.0M
YoY Change 6.18% 7.88% 10.6%
Total Long-Term Liabilities $664.7M $666.7M $4.221B
YoY Change -84.25% -79.54% 20.22%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.525B $1.561B $1.767B
Total Long-Term Liabilities $664.7M $666.7M $4.221B
Total Liabilities $2.190B $2.228B $6.010B
YoY Change -63.56% -50.43% 30.31%
SHAREHOLDERS EQUITY
Retained Earnings $4.396B $4.264B
YoY Change
Common Stock $2.349B $2.350B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.886B $2.912B
YoY Change
Treasury Stock Shares 56.74M shares 57.19M shares
Shareholders Equity $3.869B $3.693B $3.215B
YoY Change
Total Liabilities & Shareholders Equity $9.451B $9.313B $9.225B
YoY Change 2.45% 9.21% 8.33%

Cashflow Statement

Concept 2012 Q1 2011 Q4 2011 Q1
OPERATING ACTIVITIES
Net Income $159.0M $189.4M -$53.86M
YoY Change -395.2% 14.29% -133.16%
Depreciation, Depletion And Amortization $72.17M $71.70M $63.37M
YoY Change 13.9% 12.74% 0.1%
Cash From Operating Activities $161.3M $337.8M $160.6M
YoY Change 0.43% -0.5% -32.87%
INVESTING ACTIVITIES
Capital Expenditures $30.00M -$43.70M $38.99M
YoY Change -23.06% -36.76% -197.97%
Acquisitions $50.56M
YoY Change
Other Investing Activities $2.689M $2.300M $1.762M
YoY Change 52.61% -130.26% -162.93%
Cash From Investing Activities -$83.24M -$41.30M -$40.75M
YoY Change 104.26% -46.15% -4.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $50.00M $835.0M
YoY Change -94.01%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$97.47M -242.4M $425.1M
YoY Change -122.93% 32.53% -258.86%
NET CHANGE
Cash From Operating Activities $161.3M 337.8M $160.6M
Cash From Investing Activities -$83.24M -41.30M -$40.75M
Cash From Financing Activities -$97.47M -242.4M $425.1M
Net Change In Cash -$19.45M 54.10M $544.9M
YoY Change -103.57% -32.29% -867.52%
FREE CASH FLOW
Cash From Operating Activities $161.3M $337.8M $160.6M
Capital Expenditures $30.00M -$43.70M $38.99M
Free Cash Flow $131.3M $381.5M $121.6M
YoY Change 7.96% -6.63% -56.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
906764000 USD
CY2012Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
971092000 USD
CY2012Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
973888000 USD
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
906455000 USD
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
10560000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8067000 USD
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2347518000 USD
CY2012Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2347152000 USD
CY2011Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18945000 USD
CY2012Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20068000 USD
CY2011Q1 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
5765000 USD
CY2012Q1 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
4425000 USD
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
237339000 USD
CY2012Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
249513000 USD
CY2011Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9849000 USD
CY2012Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20231000 USD
CY2012Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1995000 shares
CY2011Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3746000 shares
CY2011Q4 us-gaap Assets
Assets
9313379000 USD
CY2012Q1 us-gaap Assets
Assets
9451444000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
1401260000 USD
CY2012Q1 us-gaap Assets Current
AssetsCurrent
1518604000 USD
CY2012Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 USD
CY2011Q1 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
164886000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
145439000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
449301000 USD
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
994242000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-19447000 USD
CY2011Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
544941000 USD
CY2012Q1 us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
1300000 USD
CY2011Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
20936000 USD
CY2012Q1 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
23357000 USD
CY2012Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.17
CY2011Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.10
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
600000000 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
214607000 shares
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
215059000 shares
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
2146000 USD
CY2012Q1 us-gaap Common Stock Value
CommonStockValue
2151000 USD
CY2011Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32278000 USD
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
177745000 USD
CY2011Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
7199000 USD
CY2012Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
9397000 USD
CY2011Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-25079000 USD
CY2012Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
187142000 USD
CY2011Q1 us-gaap Cost Of Revenue
CostOfRevenue
1096998000 USD
CY2012Q1 us-gaap Cost Of Revenue
CostOfRevenue
1116538000 USD
CY2011Q1 us-gaap Costs And Expenses
CostsAndExpenses
1790617000 USD
CY2012Q1 us-gaap Costs And Expenses
CostsAndExpenses
1636871000 USD
CY2012Q1 us-gaap Debt Current
DebtCurrent
554356000 USD
CY2011Q4 us-gaap Debt Current
DebtCurrent
654395000 USD
CY2012Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
4300000000 USD
CY2011Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
4400000000 USD
CY2012Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-15437000 USD
CY2011Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-38766000 USD
CY2012Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
171815000 USD
CY2011Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
153328000 USD
CY2012Q1 us-gaap Depreciation
Depreciation
51943000 USD
CY2011Q1 us-gaap Depreciation
Depreciation
53516000 USD
CY2012Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
72174000 USD
CY2011Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
63365000 USD
CY2012Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
981000 USD
CY2011Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-92000 USD
CY2012Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
707000 USD
CY2011Q1 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
282000 USD
CY2012Q1 us-gaap Future Amortization Expense Remainder Of Fiscal Year
FutureAmortizationExpenseRemainderOfFiscalYear
59857000 USD
CY2012Q1 us-gaap Future Amortization Expense Year Five
FutureAmortizationExpenseYearFive
53187000 USD
CY2012Q1 us-gaap Future Amortization Expense Year Four
FutureAmortizationExpenseYearFour
57777000 USD
CY2012Q1 us-gaap Future Amortization Expense Year One
FutureAmortizationExpenseYearOne
78205000 USD
CY2012Q1 us-gaap Future Amortization Expense Year Three
FutureAmortizationExpenseYearThree
64487000 USD
CY2012Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
0 USD
CY2011Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
0 USD
CY2012Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
27070000 USD
CY2011Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
15763000 USD
CY2012Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.17
CY2011Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.10
CY2011Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.10
CY2011Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.10
CY2011Q4 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.17
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.00
CY2011Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
CY2011Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.99
CY2011Q4 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
646000 USD
CY2012Q1 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
975000 USD
CY2011Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4680000 USD
CY2012Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3298000 USD
CY2012Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
3298000 USD
CY2011Q1 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
4680000 USD
CY2012Q1 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
50800000 USD
CY2011Q1 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
USD
CY2012Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
280561000 USD
CY2011Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
259245000 USD
CY2012Q1 us-gaap Future Amortization Expense After Year Five
FutureAmortizationExpenseAfterYearFive
343829000 USD
CY2012Q1 us-gaap Future Amortization Expense Year Two
FutureAmortizationExpenseYearTwo
75850000 USD
CY2011Q4 us-gaap Goodwill
Goodwill
5795765000 USD
CY2012Q1 us-gaap Goodwill
Goodwill
5835075000 USD
CY2010Q4 us-gaap Goodwill
Goodwill
5101938000 USD
CY2011 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
701087000 USD
CY2012Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
28144000 USD
CY2011Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-53487000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
158844000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
269618000 USD
CY2011Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
2938000 USD
CY2011Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-46288000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
168241000 USD
CY2011Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.33
CY2012Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.00
CY2012Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.99
CY2011Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.33
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
274000 USD
CY2011Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-374000 USD
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
274000 USD
CY2011Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-374000 USD
CY2011Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2011Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2012Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7609000 USD
CY2011Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
7699000 USD
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
101377000 USD
CY2011Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
49226000 USD
CY2012Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
10253000 USD
CY2011Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
10602000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-116209000 USD
CY2011Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-47126000 USD
CY2011Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
78676000 USD
CY2012Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
112039000 USD
CY2011Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
8747000 USD
CY2012Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
9932000 USD
CY2011Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
shares
CY2012Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1413000 shares
CY2011Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1035612000 USD
CY2012Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1041513000 USD
CY2012Q1 us-gaap Interest Expense
InterestExpense
42987000 USD
CY2011Q1 us-gaap Interest Expense
InterestExpense
38280000 USD
CY2012Q1 us-gaap Interest Paid
InterestPaid
49782000 USD
CY2011Q1 us-gaap Interest Paid
InterestPaid
55044000 USD
CY2011Q4 us-gaap Inventory Net
InventoryNet
89132000 USD
CY2012Q1 us-gaap Inventory Net
InventoryNet
88262000 USD
CY2011Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
351000 USD
CY2012Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
654000 USD
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9451444000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9313379000 USD
CY2011Q1 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
USD
CY2012Q1 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
269000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1561159000 USD
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1525448000 USD
CY2012Q1 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
85000000 USD
CY2012Q1 us-gaap Litigation Reserve
LitigationReserve
5000000 USD
CY2011Q4 us-gaap Litigation Reserve
LitigationReserve
5000000 USD
CY2012Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
3365257000 USD
CY2011Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
3370522000 USD
CY2012Q1 us-gaap Malpractice Loss Contingency Accrual Undiscounted
MalpracticeLossContingencyAccrualUndiscounted
165000000 USD
CY2011Q1 us-gaap Malpractice Loss Contingency Accrual Undiscounted
MalpracticeLossContingencyAccrualUndiscounted
127000000 USD
CY2012Q1 us-gaap Minority Interest
MinorityInterest
26764000 USD
CY2011Q4 us-gaap Minority Interest
MinorityInterest
22127000 USD
CY2012Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
5884000 USD
CY2011Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
5268000 USD
CY2012Q1 us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">DESCRIPTION OF BUSINESS</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Background</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") is the world's leading provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make better healthcare decisions. Quest Diagnostics offers patients and physicians the broadest access to diagnostic laboratory services through the Company's nationwide network of laboratories and patient service centers. The Company provides interpretive consultation through the largest medical and scientific staff in the industry, with hundreds of M.D.s and Ph.D.s, primarily</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">located in the United States. Quest Diagnostics is the leading provider of clinical testing, including gene-based and esoteric testing, and anatomic pathology services, and the leading provider of risk assessment services for the life insurance industry in North America. The Company is also a leading provider of testing for clinical trials and testing for drugs-of-abuse. The Company's diagnostics products business manufactures and markets diagnostic test kits and specialized point-of-care testing. Quest Diagnostics empowers healthcare organizations and clinicians with robust information technology solutions.</font></div></div>
CY2011Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
425114000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-97471000 USD
CY2011Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-40753000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-83243000 USD
CY2011Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
160580000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
161267000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
159118000 USD
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
-53861000 USD
CY2011Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7199000 USD
CY2012Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
9397000 USD
CY2012Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-29967000 USD
CY2011Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-28022000 USD
CY2012Q1 us-gaap Notional Amount Of Foreign Currency Derivatives
NotionalAmountOfForeignCurrencyDerivatives
34400000 USD
CY2011Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
30960000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
299585000 USD
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
329919000 USD
CY2012Q1 us-gaap Other Assets Current
OtherAssetsCurrent
399277000 USD
CY2012Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
274825000 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
280971000 USD
CY2011Q1 us-gaap Other Comprehensive Income Available For Sale Securities Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease
-1250000 USD
CY2012Q1 us-gaap Other Comprehensive Income Available For Sale Securities Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeAvailableForSaleSecuritiesAdjustmentNetOfTaxPeriodIncreaseDecrease
201000 USD
CY2011Q1 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease
-1671000 USD
CY2012Q1 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease
210000 USD
CY2012Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
18216000 USD
CY2011Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease
24504000 USD
CY2011Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
21583000 USD
CY2012Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
18627000 USD
CY2012Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
664682000 USD
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
666699000 USD
CY2012Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
197000 USD
CY2011Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3474000 USD
CY2011Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2208000 USD
CY2012Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4757000 USD
CY2011Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1762000 USD
CY2012Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
2689000 USD
CY2012Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
50000000 USD
CY2011Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
835001000 USD
CY2011Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
17136000 USD
CY2012Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
26900000 USD
CY2012Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
5884000 USD
CY2011Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
5268000 USD
CY2012Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
50556000 USD
CY2011Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
USD
CY2011Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38991000 USD
CY2012Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29998000 USD
CY2011Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-17387000 USD
CY2012Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
19928000 USD
CY2012Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
64399000 USD
CY2011Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
53788000 USD
CY2011Q1 us-gaap Profit Loss
ProfitLoss
-46662000 USD
CY2012Q1 us-gaap Profit Loss
ProfitLoss
168515000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
799771000 USD
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
781427000 USD
CY2011Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
77376000 USD
CY2012Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
80718000 USD
CY2011Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
576891000 USD
CY2012Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
467312000 USD
CY2012Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4395647000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4263599000 USD
CY2012Q1 us-gaap Sales Revenue Net
SalesRevenueNet
1936456000 USD
CY2011Q1 us-gaap Sales Revenue Net
SalesRevenueNet
1821577000 USD
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
500641000 USD
CY2011Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
447858000 USD
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
20068000 USD
CY2011Q1 us-gaap Share Based Compensation
ShareBasedCompensation
18945000 USD
CY2011Q1 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
1400000 shares
CY2012Q1 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
1500000 shares
CY2011Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4667000 USD
CY2012Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4587000 USD
CY2012Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
64399000 USD
CY2011Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
53788000 USD
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
3869293000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
3692872000 USD
CY2012Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3896057000 USD
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3714999000 USD
CY2010Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4054125000 USD
CY2011Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
3238004000 USD
CY2011Q4 us-gaap Trading Account Assets Fair Value Disclosure
TradingAccountAssetsFairValueDisclosure
46926000 USD
CY2012Q1 us-gaap Trading Account Assets Fair Value Disclosure
TradingAccountAssetsFairValueDisclosure
50155000 USD
CY2011Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
57187000 shares
CY2012Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
56541000 shares
CY2011Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2912324000 USD
CY2012Q1 us-gaap Treasury Stock Value
TreasuryStockValue
2886217000 USD
CY2011Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
835001000 USD
CY2012Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
50000000 USD
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
159706000 shares
CY2011Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
161489000 shares
CY2011Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
161489000 shares
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
158293000 shares
CY2012Q1 dgx Accounts Receivable
AccountsReceivable
147174000 USD
CY2011Q1 dgx Accounts Receivable
AccountsReceivable
171275000 USD
CY2012Q1 dgx Accumulated Net Gain Loss From Designated Or Qualifying Cash Flow Hedges
AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges
7400000 USD
CY2011 dgx Accumulated Net Gain Loss From Designated Or Qualifying Cash Flow Hedges
AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedges
7700000 USD
CY2011Q2 dgx Agreement In Principle Amount Medi Cal Matter
AgreementInPrincipleAmountMediCalMatter
241000000 USD
CY2012Q1 dgx Assets Acquired Under Capital Lease
AssetsAcquiredUnderCapitalLease
1192000 USD
CY2011Q1 dgx Assets Acquired Under Capital Lease
AssetsAcquiredUnderCapitalLease
821000 USD
CY2012Q1 dgx Bank Guarantees
BankGuarantees
5000000 USD
CY2011Q1 dgx Cash Paid For Business Acquisitions
CashPaidForBusinessAcquisitions
USD
CY2012Q1 dgx Cash Paid For Business Acquisitions
CashPaidForBusinessAcquisitions
50556000 USD
CY2011Q1 dgx Changes In Operating Assets And Liabilties Summarized
ChangesInOperatingAssetsAndLiabiltiesSummarized
148472000 USD
CY2012Q1 dgx Changes In Operating Assets And Liabilties Summarized
ChangesInOperatingAssetsAndLiabiltiesSummarized
161276000 USD
CY2012Q1 dgx Debt Instrument Fair Value In Excess Of Carrying Value Of Debt
DebtInstrumentFairValueInExcessOfCarryingValueOfDebt
367000000 USD
CY2011Q4 dgx Debt Instrument Fair Value In Excess Of Carrying Value Of Debt
DebtInstrumentFairValueInExcessOfCarryingValueOfDebt
387000000 USD
CY2012Q1 dgx Decrease Increase Related To Foreign Currency Translation
DecreaseIncreaseRelatedToForeignCurrencyTranslation
11166000 USD
CY2011 dgx Decrease Increase Related To Foreign Currency Translation
DecreaseIncreaseRelatedToForeignCurrencyTranslation
-7260000 USD
CY2011Q4 dgx Deferred Compensation Liabilities Fair Value Disclosure
DeferredCompensationLiabilitiesFairValueDisclosure
71688000 USD
CY2012Q1 dgx Deferred Compensation Liabilities Fair Value Disclosure
DeferredCompensationLiabilitiesFairValueDisclosure
77726000 USD
CY2011Q1 dgx Earnings Allocated To Nonvested Share Based Payment Awards
EarningsAllocatedToNonvestedShareBasedPaymentAwards
90000 USD
CY2012Q1 dgx Earnings Allocated To Nonvested Share Based Payment Awards
EarningsAllocatedToNonvestedShareBasedPaymentAwards
604000 USD
CY2011Q1 dgx Earnings Available To Quest Diagnostics Common Stockholders Basic And Diluted
EarningsAvailableToQuestDiagnosticsCommonStockholdersBasicAndDiluted
-53577000 USD
CY2012Q1 dgx Earnings Available To Quest Diagnostics Common Stockholders Basic And Diluted
EarningsAvailableToQuestDiagnosticsCommonStockholdersBasicAndDiluted
158240000 USD
CY2012Q1 dgx Equity Earnings From Subsidiaries
EquityEarningsFromSubsidiaries
USD
CY2011Q1 dgx Equity Earnings From Subsidiaries
EquityEarningsFromSubsidiaries
USD
CY2012Q1 dgx Estimated Amortization Expense Total
EstimatedAmortizationExpenseTotal
733192000 USD
CY2012Q1 dgx Fair Value Of Net Assets Acquired
FairValueOfNetAssetsAcquired
50531000 USD
CY2011Q1 dgx Fair Value Of Net Assets Acquired
FairValueOfNetAssetsAcquired
USD
CY2012Q1 dgx Future Amortization Expense Intangible Assets Textblock
FutureAmortizationExpenseIntangibleAssetsTextblock
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March&#160;31, 2012</font><font style="font-family:inherit;font-size:10pt;"> is as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:42.96875%;border-collapse:collapse;text-align:left;"><tr><td colspan="4" rowspan="1"></td></tr><tr><td width="70%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="28%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fiscal Year Ending December 31,</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Remainder of 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59,857</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2013</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">78,205</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2014</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75,850</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2015</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">64,487</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">57,777</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">53,187</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Thereafter</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">343,829</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">733,192</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>
CY2011Q4 dgx Goodwill And Intangible Assets Net
GoodwillAndIntangibleAssetsNet
6831377000 USD
CY2012Q1 dgx Goodwill And Intangible Assets Net
GoodwillAndIntangibleAssetsNet
6876588000 USD
CY2012Q1 dgx Goodwill As Percentage Of Clinical Testing Business
GoodwillAsPercentageOfClinicalTestingBusiness
0.90
CY2011Q4 dgx Goodwill As Percentage Of Clinical Testing Business
GoodwillAsPercentageOfClinicalTestingBusiness
0.9000
CY2012Q1 dgx Income From Continuing Operations Before Taxes
IncomeFromContinuingOperationsBeforeTaxes
269618000 USD
CY2011Q1 dgx Income From Continuing Operations Before Taxes
IncomeFromContinuingOperationsBeforeTaxes
2938000 USD
CY2011Q4 dgx Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1294857000 USD
CY2012Q1 dgx Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1322074000 USD
CY2011Q4 dgx Intercompany Receivable Payable
IntercompanyReceivablePayable
USD
CY2012Q1 dgx Intercompany Receivable Payable
IntercompanyReceivablePayable
USD
CY2011Q1 dgx Interest Expense Net
InterestExpenseNet
37929000 USD
CY2012Q1 dgx Interest Expense Net
InterestExpenseNet
42333000 USD
CY2011Q4 dgx Investment In Subsidiaries
InvestmentInSubsidiaries
USD
CY2012Q1 dgx Investment In Subsidiaries
InvestmentInSubsidiaries
USD
CY2012Q1 dgx Merger Consideration Paid
MergerConsiderationPaid
25000 USD
CY2011Q1 dgx Merger Consideration Paid
MergerConsiderationPaid
USD
CY2011Q4 dgx Original Dividend Payable Per Share
OriginalDividendPayablePerShare
0.10
CY2011Q1 dgx Other Net Summarized
OtherNetSummarized
-21027000 USD
CY2012Q1 dgx Other Net Summarized
OtherNetSummarized
1136000 USD
CY2012Q1 dgx Other Non Controlling Interests
OtherNonControllingInterests
-1124000 USD
CY2011Q1 dgx Other Non Controlling Interests
OtherNonControllingInterests
-838000 USD
CY2012Q1 dgx Other Operating Expense Income Net
OtherOperatingExpenseIncomeNet
-539000 USD
CY2011Q1 dgx Other Operating Expense Income Net
OtherOperatingExpenseIncomeNet
235912000 USD
CY2011Q2 dgx Payment For Medi Cal Matter
PaymentForMediCalMatter
241000000 USD
CY2012Q1 dgx Percentage Of Net Revenues From Clinical Testing Business
PercentageOfNetRevenuesFromClinicalTestingBusiness
0.90
CY2011Q1 dgx Percentage Of Net Revenues From Clinical Testing Business
PercentageOfNetRevenuesFromClinicalTestingBusiness
0.9000
CY2012Q1 dgx Prepaid Expenses And Other Current Assets
PrepaidExpensesAndOtherCurrentAssets
139200000 USD
CY2011Q4 dgx Prepaid Expenses And Other Current Assets
PrepaidExpensesAndOtherCurrentAssets
87459000 USD
CY2011Q1 dgx Proceeds From Borrowings
ProceedsFromBorrowings
1818329000 USD
CY2012Q1 dgx Proceeds From Borrowings
ProceedsFromBorrowings
365000000 USD
CY2011Q1 dgx Provision For Special Charge Medi Cal Matter
ProvisionForSpecialChargeMediCalMatter
236000000 USD
CY2011Q1 dgx Provision For Special Charges
ProvisionForSpecialCharges
236000000 USD
CY2012Q1 dgx Provision For Special Charges
ProvisionForSpecialCharges
USD
CY2012Q1 dgx Royalty Income Expense
RoyaltyIncomeExpense
USD
CY2011Q1 dgx Royalty Income Expense
RoyaltyIncomeExpense
USD
CY2012Q1 dgx Schedule Of Derivative Instruments In Statement Of Financial Position Fair Value Disclosure Textblock
ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueDisclosureTextblock
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A summary of the fair values of derivative instruments in the consolidated balance sheets is stated in the table below:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="43%" rowspan="1" colspan="1"></td><td width="19%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="19%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="6%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">March&#160;31, 2012</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">December&#160;31, 2011</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance Sheet</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Classification</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance Sheet</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Classification</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives Designated as Hedging Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset Derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest rate swaps</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,265</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">56,520</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Derivatives Not Designated as Hedging Instruments</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset Derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">482</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liability Derivatives:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency forward contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">461</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,648</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Net Derivatives Asset</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">51,286</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">55,052</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>
CY2012Q1 dgx Share Repurchase Authorization Remaining Available
ShareRepurchaseAuthorizationRemainingAvailable
1000000000 USD
CY2012Q1 dgx Share Repurchase Authorization Remaining Available
ShareRepurchaseAuthorizationRemainingAvailable
1100000000 USD
CY2011Q1 dgx Shares To Cover Employee Payroll Tax Withholdings On Stock Benefit Plans Value
SharesToCoverEmployeePayrollTaxWithholdingsOnStockBenefitPlansValue
-19013000 USD
CY2012Q1 dgx Shares To Cover Employee Payroll Tax Withholdings On Stock Benefit Plans Value
SharesToCoverEmployeePayrollTaxWithholdingsOnStockBenefitPlansValue
-17733000 USD
CY2011Q4 dgx Total Recognized Assets Measured At Fair Value On Recurring Basis
TotalRecognizedAssetsMeasuredAtFairValueOnRecurringBasis
125208000 USD
CY2012Q1 dgx Total Recognized Assets Measured At Fair Value On Recurring Basis
TotalRecognizedAssetsMeasuredAtFairValueOnRecurringBasis
126234000 USD
CY2011Q4 dgx Total Recognized Liabilities Measured At Fair Value On Recurring Basis
TotalRecognizedLiabilitiesMeasuredAtFairValueOnRecurringBasis
73336000 USD
CY2012Q1 dgx Total Recognized Liabilities Measured At Fair Value On Recurring Basis
TotalRecognizedLiabilitiesMeasuredAtFairValueOnRecurringBasis
78187000 USD
CY2012Q1 dgx Treasury Stock Acquired Repurchase Per Share
TreasuryStockAcquiredRepurchasePerShare
59.00
CY2012Q1 dgx Treasury Stock Shares Acquired Disclosure
TreasuryStockSharesAcquiredDisclosure
847000 shares
CY2012Q1 dgx Treasury Stock Value Acquired Cost Method Disclosure
TreasuryStockValueAcquiredCostMethodDisclosure
50000000 USD
CY2012Q1 dgx Treasury Stock Value Aquired Repurchase Program
TreasuryStockValueAquiredRepurchaseProgram
1000000000 USD
CY2012Q1 dei Amendment Flag
AmendmentFlag
false
CY2012Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2012Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2012Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012Q1 dei Document Period End Date
DocumentPeriodEndDate
2012-03-31
CY2012Q1 dei Document Type
DocumentType
10-Q
CY2012Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001022079
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
158650374 shares
CY2012Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2012Q1 dei Entity Registrant Name
EntityRegistrantName
QUEST DIAGNOSTICS INC

Files In Submission

Name View Source Status
R2.htm Edgar Link pending
0001022079-12-000005-index-headers.html Edgar Link pending
0001022079-12-000005-index.html Edgar Link pending
0001022079-12-000005.txt Edgar Link pending
0001022079-12-000005-xbrl.zip Edgar Link pending
dgx-20120331.xml Edgar Link completed
dgx-20120331.xsd Edgar Link pending
dgx-20120331_cal.xml Edgar Link unprocessable
dgx-20120331_def.xml Edgar Link unprocessable
dgx-20120331_lab.xml Edgar Link unprocessable
dgx-20120331_pre.xml Edgar Link unprocessable
dgx0331201210-q.htm Edgar Link pending
dgx03312012ex311.htm Edgar Link pending
dgx03312012ex312.htm Edgar Link pending
dgx03312012ex321.htm Edgar Link pending
dgx03312012ex322.htm Edgar Link pending
dgx3312012ex101_thecelerac.htm Edgar Link pending
dgx3312012ex102_thecelerac.htm Edgar Link pending
dgx3312012ex103_celera401k.htm Edgar Link pending
dgx3312012ex104_celera401k.htm Edgar Link pending
dgx3312012ex105_celera401k.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending